Studies have shown that disturbances in gut microbiota composition and their metabolic activities, such as reduced production of secondary bile acids and indole derivatives, can suppress glucagon-like peptide-1 (GLP-1) secretion, thereby contributing to elevated insulin resistance [125, 126]. The gene discussed is GCG; the disease is Insulin resistance.